Kymera Therapeutics, Inc. (KYMR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1251251,
    "name": "Kymera Therapeutics, Inc.",
    "stock_name": "Kymera Therapeutics, Inc.",
    "full_name": "Kymera Therapeutics, Inc.",
    "name_url": "stocks-analysis/kymera-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "66.23",
    "chg": 1.96,
    "chgp": "3.05%",
    "dir": 1,
    "prev_price": "64.27",
    "mcapval": "3,092.99",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US5015751044",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.48 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kymera-therapeutics-inc-1251251-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kymera Therapeutics Hits Day High with 7.95% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kymera-therapeutics-hits-day-high-with-795-surge-in-stock-price-3626743",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/KymeraTherapeut_priceRelatedfactors_3626743.png",
        "date": "2025-10-16 19:06:00",
        "description": "Kymera Therapeutics, Inc. has seen a significant rise in its stock price, outperforming the S&P 500 over the past week. Despite a strong year-to-date performance, the company faces challenges, including negative operating profit growth and declining net sales, while maintaining a market capitalization of USD 3,093 million."
      },
      {
        "title": "Kymera Therapeutics Hits New 52-Week High of $63.29, Up 83.57%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kymera-therapeutics-hits-new-52-week-high-of-6329-up-8357-3626666",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/KymeraTherapeut_priceRelatedfactors_3626666.png",
        "date": "2025-10-16 18:27:53",
        "description": "Kymera Therapeutics, Inc. has achieved a new 52-week high of USD 63.29, reflecting an 83.57% increase over the past year. With a market capitalization of approximately USD 3,093 million, the company operates at a loss and has a unique financial structure, indicated by its negative price-to-earnings ratio."
      },
      {
        "title": "Kymera Therapeutics Hits New 52-Week High at $60.00, Up 74.81% Year-to-Date",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kymera-therapeutics-hits-new-52-week-high-at-6000-up-7481-year-to-date-3620150",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/KymeraTherapeut_priceRelatedfactors_3620150.png",
        "date": "2025-10-14 18:56:49",
        "description": "Kymera Therapeutics, Inc. achieved a new 52-week high of USD 60.00 on October 13, 2025, reflecting a significant increase from its low of USD 19.45. With a market capitalization of USD 3,093 million, the company operates in the competitive Pharmaceuticals & Biotechnology sector, despite currently reporting losses."
      },
      {
        "title": "Kymera Therapeutics Hits New 52-Week High of $59.00, Up 69%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kymera-therapeutics-hits-new-52-week-high-of-5900-up-69-3595676",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/KymeraTherapeut_priceRelatedfactors_3595676.png",
        "date": "2025-10-06 17:42:00",
        "description": "Kymera Therapeutics, Inc. has achieved a new 52-week high of USD 59.00, significantly up from its low of USD 19.45. The company, with a market cap of approximately USD 3,093 million, has shown strong stock performance despite ongoing losses and a negative return on equity."
      },
      {
        "title": "Kymera Therapeutics Hits New 52-Week High of $58.93, Up 65.21%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kymera-therapeutics-hits-new-52-week-high-of-5893-up-6521-3586078",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/KymeraTherapeut_priceRelatedfactors_3586078.png",
        "date": "2025-10-01 16:44:12",
        "description": "Kymera Therapeutics, Inc. achieved a new 52-week high of USD 58.93 on September 30, 2025, reflecting a significant performance increase from its 52-week low. The company, with a market cap of approximately USD 3,093 million, continues to attract attention despite its loss-making status and challenging financial metrics."
      },
      {
        "title": "Kymera Therapeutics Hits New 52-Week High of $56.81, Up 64% Year-to-Date",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kymera-therapeutics-hits-new-52-week-high-of-5681-up-64-year-to-date-3579394",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/KymeraTherapeut_priceRelatedfactors_3579394.png",
        "date": "2025-09-29 14:31:27",
        "description": "Kymera Therapeutics, Inc. achieved a new 52-week high, reflecting strong performance in the pharmaceuticals and biotechnology sector. With a market capitalization of USD 3,093 million, the company has seen significant growth over the past year, despite being loss-making and lacking a dividend yield. Key financial metrics indicate a unique financial structure."
      },
      {
        "title": "Kymera Therapeutics Hits New 52-Week High of $53.84, Reflecting Strong Growth",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kymera-therapeutics-hits-new-52-week-high-of-5384-reflecting-strong-growth-3574516",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/KymeraTherapeut_priceRelatedfactors_3574516.png",
        "date": "2025-09-26 15:16:05",
        "description": "Kymera Therapeutics, Inc. achieved a new 52-week high of USD 53.84 on September 25, 2025, highlighting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a significant increase over the past year, attracting attention despite being loss-making, with key financial metrics indicating its market valuation and positioning."
      },
      {
        "title": "Kymera Therapeutics Experiences Revision in Stock Evaluation Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kymera-therapeutics-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-positive-indicators-3552676",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/KymeraTherapeut_technicaldot_3552676.png",
        "date": "2025-09-22 18:20:50",
        "description": "Kymera Therapeutics, Inc. has recently revised its evaluation amid market fluctuations, with its stock price at $49.13. The company has shown significant volatility over the past year, achieving notable returns compared to the S&P 500, indicating resilience in a competitive landscape despite mixed technical signals."
      },
      {
        "title": "Is Kymera Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kymera-therapeutics-inc-technically-bullish-or-bearish-3547826",
        "imagepath": "",
        "date": "2025-09-20 20:03:54",
        "description": "As of 5 August 2025, the technical trend for Kymera Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also reflect a bullish stance in both time frames. Daily moving averages are bullish, while the KST shows a mildly bearish signal on both weekly and monthly charts. Dow Theory indicates a mildly bullish trend as well. The stock has outperformed the S&P 500 over multiple periods, with a 1-week return of 10.74% compared to 1.05% for the benchmark, and a year-to-date return of 27.17% against 12.22%. Overall, the current technical stance is mildly bullish, supported by strong momentum indicators and positive returns relative to the S&P 500...."
      }
    ],
    "total": 12,
    "sid": "1251251",
    "stock_news_url": "https://www.marketsmojo.com/news/kymera-therapeutics-inc-1251251"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Kymera Therapeutics Hits Day High with 7.95% Surge in Stock Price

2025-10-16 19:06:00

Kymera Therapeutics, Inc. has seen a significant rise in its stock price, outperforming the S&P 500 over the past week. Despite a strong year-to-date performance, the company faces challenges, including negative operating profit growth and declining net sales, while maintaining a market capitalization of USD 3,093 million.

Kymera Therapeutics Hits New 52-Week High of $63.29, Up 83.57%

2025-10-16 18:27:53

Kymera Therapeutics, Inc. has achieved a new 52-week high of USD 63.29, reflecting an 83.57% increase over the past year. With a market capitalization of approximately USD 3,093 million, the company operates at a loss and has a unique financial structure, indicated by its negative price-to-earnings ratio.

Kymera Therapeutics Hits New 52-Week High at $60.00, Up 74.81% Year-to-Date

2025-10-14 18:56:49

Kymera Therapeutics, Inc. achieved a new 52-week high of USD 60.00 on October 13, 2025, reflecting a significant increase from its low of USD 19.45. With a market capitalization of USD 3,093 million, the company operates in the competitive Pharmaceuticals & Biotechnology sector, despite currently reporting losses.

Kymera Therapeutics Hits New 52-Week High of $59.00, Up 69%

2025-10-06 17:42:00

Kymera Therapeutics, Inc. has achieved a new 52-week high of USD 59.00, significantly up from its low of USD 19.45. The company, with a market cap of approximately USD 3,093 million, has shown strong stock performance despite ongoing losses and a negative return on equity.

Kymera Therapeutics Hits New 52-Week High of $58.93, Up 65.21%

2025-10-01 16:44:12

Kymera Therapeutics, Inc. achieved a new 52-week high of USD 58.93 on September 30, 2025, reflecting a significant performance increase from its 52-week low. The company, with a market cap of approximately USD 3,093 million, continues to attract attention despite its loss-making status and challenging financial metrics.

Kymera Therapeutics Hits New 52-Week High of $56.81, Up 64% Year-to-Date

2025-09-29 14:31:27

Kymera Therapeutics, Inc. achieved a new 52-week high, reflecting strong performance in the pharmaceuticals and biotechnology sector. With a market capitalization of USD 3,093 million, the company has seen significant growth over the past year, despite being loss-making and lacking a dividend yield. Key financial metrics indicate a unique financial structure.

Kymera Therapeutics Hits New 52-Week High of $53.84, Reflecting Strong Growth

2025-09-26 15:16:05

Kymera Therapeutics, Inc. achieved a new 52-week high of USD 53.84 on September 25, 2025, highlighting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a significant increase over the past year, attracting attention despite being loss-making, with key financial metrics indicating its market valuation and positioning.

Kymera Therapeutics Experiences Revision in Stock Evaluation Amid Mixed Market Signals

2025-09-22 18:20:50

Kymera Therapeutics, Inc. has recently revised its evaluation amid market fluctuations, with its stock price at $49.13. The company has shown significant volatility over the past year, achieving notable returns compared to the S&P 500, indicating resilience in a competitive landscape despite mixed technical signals.

Is Kymera Therapeutics, Inc. technically bullish or bearish?

2025-09-20 20:03:54

As of 5 August 2025, the technical trend for Kymera Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also reflect a bullish stance in both time frames. Daily moving averages are bullish, while the KST shows a mildly bearish signal on both weekly and monthly charts. Dow Theory indicates a mildly bullish trend as well. The stock has outperformed the S&P 500 over multiple periods, with a 1-week return of 10.74% compared to 1.05% for the benchmark, and a year-to-date return of 27.17% against 12.22%. Overall, the current technical stance is mildly bullish, supported by strong momentum indicators and positive returns relative to the S&P 500....

View All News